Rebecca Cardone, MScResearch Associate 4, MSDownloadHi-Res PhotoCardsContact Inforebecca.cardone@yale.eduLearn moreabout Contact InfoAboutResearchLinksGet In TouchAboutCopy LinkTitlesResearch Associate 4, MSDepartments & OrganizationsInternal MedicineKibbey LabEducation & TrainingMScQuinnipiac University (2008)ResearchCopy LinkResearch at a GlanceYale Co-AuthorsFrequent collaborators of Rebecca Cardone's published research.Akin SogunroView Full ProfileView Common PublicationBoby MathewView Full ProfileView Common PublicationChristian Felipe Ruiz, PhDView Full ProfileView Common PublicationChristy ZhengView Full ProfileView Common PublicationDaniel McQuaidView Full ProfileView Common PublicationKen Huaijin Loh, PhD, BScView Full ProfileView Common PublicationPublications2026Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma developmentGarcia CC, Venkat A, McQuaid DC, Agabiti SS, Tong A, Mathew B, Cardone RL, Starble R, Ruiz CF, Zheng C, Sogunro A, Jacox JB, Loh KH, Kibbey RG, Krishnaswamy S, Muzumdar MD. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026 DOI: 10.1038/s41467-026-69821-2.Peer-Reviewed Original ResearchThis study investigates how beta cell-derived cholecystokinin drives obesity-associated pancreatic cancer development, showing that targeting endocrine signaling could prevent tumor progression in obesity-related contexts.Full SummaryNewsCopy LinkNewsAugust 08, 2022Internal Medicine Staffers Celebrate Milestone Anniversaries in 2022Read moreabout Internal Medicine Staffers Celebrate Milestone Anniversaries in 2022Get In TouchCopy LinkContactsEmailrebecca.cardone@yale.edu
Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma developmentGarcia CC, Venkat A, McQuaid DC, Agabiti SS, Tong A, Mathew B, Cardone RL, Starble R, Ruiz CF, Zheng C, Sogunro A, Jacox JB, Loh KH, Kibbey RG, Krishnaswamy S, Muzumdar MD. Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Nature Communications 2026 DOI: 10.1038/s41467-026-69821-2.Peer-Reviewed Original ResearchThis study investigates how beta cell-derived cholecystokinin drives obesity-associated pancreatic cancer development, showing that targeting endocrine signaling could prevent tumor progression in obesity-related contexts.Full Summary
August 08, 2022Internal Medicine Staffers Celebrate Milestone Anniversaries in 2022Read moreabout Internal Medicine Staffers Celebrate Milestone Anniversaries in 2022